Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1025-07-6

Post Buying Request

1025-07-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1025-07-6 Usage

Chemical class

Phenanthroline derivatives

Subclass

Carbohydrazonamide derivatives

Potential activities

Antineoplastic and antitumor

Structure

Contains a phenanthroline core and a carbohydrazonamide group

Function

Acts as a metal chelator

Mechanism of action

Potentially inhibits the activity of metal-dependent enzymes involved in tumor cell proliferation and metastasis

Therapeutic applications

Studied for potential use in cancer treatment

Research status

Ongoing research to explore mechanisms of action and potential clinical use
This list provides a concise overview of the key characteristics and information about 1,10-phenanthroline-2-carbohydrazonamide, as described in the material.

Check Digit Verification of cas no

The CAS Registry Mumber 1025-07-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,0,2 and 5 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1025-07:
(6*1)+(5*0)+(4*2)+(3*5)+(2*0)+(1*7)=36
36 % 10 = 6
So 1025-07-6 is a valid CAS Registry Number.

1025-07-6Relevant articles and documents

Ruthenium(II) complexes containing novel asymmetric tridentate ligands: Synthesis, structure, electrochemical and spectroscopic properties

Chao,Yang,Xue,Li,Zang,Williams,Ji,Chen,Li

, p. 1326 - 1331 (2001)

Three novel asymmetrical tridentate ligands, 3-(1,10-phenanthrolin-2-yl)-5,6-diphenyl-as-triazine (dppt), 3-(1,10-phenanthrolin-2-yl)-as-triazino[5,6-f]acenaphthylene (pta) and 3-(1,10-phenanthrolin-2-yl)-as-triazino-[5,6-f]phenanthrene (ptp) have been prepared. Their homoleptic ruthenium complexes [Ru(L)2]2+ (L = dppt, pta or ptp) and heteroleptic ruthenium complexes [Ru(tpy)(L)]2+ have been synthesized and characterized by 1H NMR, ES-MS, electronic absorption spectroscopy and cyclic voltammetry. The heteroleptic ruthenium complexes were also characterized by X-ray crystallography. The electrochemical and spectroscopic studies of the complexes display the changes in properties in comparison with [Ru(tpy)3]2+ owing to the structural differences.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1025-07-6